Journal article
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
Abstract
PURPOSE: A large proportion of the practice of radiotherapy in the management of metastatic adenocarcinoma of the prostate is associated with palliation of pain from osseous metastases and improving quality of life. Radiation therapy is well known to be effective in treating painful sites and may also be effective in reducing the propensity for adjuvantly treated disease to become symptomatic. Strontium-89 is a systemic radionuclide that has …
Authors
Porter AT; McEwan AJB; Powe JE; Reid R; McGowan DG; Lukka H; Sathyanarayana JR; Yakemchuk VN; Thomas GM; Erlich LE
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 25, No. 5, pp. 805–813
Publisher
Elsevier
Publication Date
April 1993
DOI
10.1016/0360-3016(93)90309-j
ISSN
0360-3016